Velo3D, Inc. (VLD) - Q2 2024 10-Q Summary
Business Context and Reporting Period
This report covers the quarterly period ended June 30, 2024. Velo3D, Inc. is a developer of metal additive manufacturing (3D printing) systems, primarily the Sapphire family of printers, serving aerospace, defense, and industrial markets. The company is currently classified as an emerging growth company and a smaller reporting company. Management has initiated a strategic realignment to pivot from revenue growth to optimizing free cash flow and reducing expenditures.
Key Financial Metrics
| Metric | Q2 2024 (3 Months) | Q2 2023 (3 Months) | YTD 2024 (6 Months) | YTD 2023 (6 Months) |
|---|---|---|---|---|
| Total Revenue | $10.3 million | $25.1 million | $20.1 million | $51.8 million |
| Gross Profit (Loss) | $(2.9) million | $2.5 million | $(5.7) million | $5.1 million |
| Gross Margin | (28.0)% | 10.1% | (28.4)% | 9.8% |
| Net Loss | $(0.2) million | $(23.2) million | $(28.5) million | $(59.5) million |
| Operating Cash Flow | Not provided for Q2 | Not provided for Q2 | $(28.5) million | $(58.8) million |
| Cash & Short-term Investments | $3.2 million (as of June 30) | $31.1 million (as of Dec 31, 2023) | Note: Cash dropped to ~$1.1 million as of August 2, 2024 | |
| Total Debt (Secured Notes) | $24.6 million (current portion) | $21.2 million (current portion) | Principal outstanding: ~$27.9 million |
Material Changes vs. Prior Period
- Revenue Decline: Total revenue decreased 58.8% year-over-year in Q2 2024, driven primarily by a 62.6% drop in 3D Printer sales due to fewer systems sold and customer order delays.
- Gross Margin Deterioration: The company reported a negative gross margin of (28.0)% in Q2 2024 compared to 10.1% in Q2 2023. This was caused by lower sales volume failing to absorb fixed manufacturing costs and increased component costs due to unfavorable supplier terms.
- Net Loss Improvement: While the company remains unprofitable, the net loss narrowed significantly to $0.2 million in Q2 2024 from $23.2 million in Q2 2023. This improvement was largely due to a non-cash gain of $25.3 million on the fair value of warrants, offsetting operating losses.
- Liquidity Crisis: Cash and short-term investments plummeted from $31.1 million at year-end 2023 to $3.2 million at June 30, 2024, and further to approximately $1.1 million as of August 2, 2024.
Guidance, Outlook, Risks, and Unusual Items
- Going Concern Warning: Management has expressed substantial doubt about the company's ability to continue as a going concern for the next 12 months. Current liquidity is insufficient to meet operating needs and debt obligations.
- Debt Restructuring: The company entered into a "Third Note Amendment" on July 1, 2024, deferring a $10.5 million redemption payment over ten months. In exchange, investors received warrants to purchase 1.65 million shares at $3.00 per share. A default notice regarding covenant compliance was received in July but subsequently waived.
- NYSE Listing Status: The company received notice from the NYSE on July 8, 2024, regarding non-compliance with market capitalization and stockholders' equity standards. A plan to regain compliance must be submitted within 45 days.
- Workforce Reduction: On August 9, 2024, the company initiated a reduction in force affecting 63 employees (approx. 30% of the workforce), with estimated costs of $1.1 million to $1.7 million.
- Warrant Inducement: On August 12, 2024, the company entered an agreement to reduce the exercise price of certain existing warrants from $19.78 to $2.28 and issued new warrants to raise potential proceeds of up to $1.6 million.
- Internal Controls: The company disclosed material weaknesses in internal controls over financial reporting, including issues with segregation of duties, inventory accounting, and debt/equity instrument accounting. These have not been remediated as of June 30, 2024.
Investor Verification Checklist
- Liquidity Runway: Verify the exact cash balance as of the most recent date (reported as ~$1.1M in early August) against immediate payroll and debt obligations.
- Debt Covenants: Monitor compliance with the Secured Notes covenants, specifically the minimum revenue and cash requirements, to avoid acceleration of debt.
- Financing Progress: Track the status of the "Third Note Amendment" payments and the success of the warrant inducement exercise to determine if additional capital will be raised.
- NYSE Compliance Plan: Review the company's submitted plan to the NYSE to avoid delisting and assess the feasibility of meeting the 18-month cure period.
- Supplier Relations: Assess the impact of paying suppliers in advance or at a premium on future production capabilities and gross margins.
- Internal Control Remediation: Evaluate the timeline and effectiveness of the remediation plan for material weaknesses in financial reporting.